ArticleslgStudy

chemistry

Futibatinib

Futibatinib is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Futibatinib rather than just read about it. In short: Futibatinib, sold under the brand name Lytgobi, is an anti-cancer medication used for the treatment of cholangiocarcinoma (bile duct cancer). It is a kinase inhibitor.

Futibatinib — main illustration
Futibatinib — illustration

Key takeaways

  • Futibatinib belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Futibatinib to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Futibatinib from memory before moving on to harder problems.

Reference excerpt

Futibatinib, sold under the brand name Lytgobi, is an anti-cancer medication used for the treatment of cholangiocarcinoma (bile duct cancer). It is a kinase inhibitor. It is taken by mouth. Futibatinib was approved for medical use in the United States in September 2022, in Japan in June 2023 and in the European Union in July 2023.

Medical uses Futibatinib is indicated for the treatment of adults with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements.

Society and culture

Legal status On 26 April 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a conditional marketing authorization for the medicinal product Lytgobi, intended for the second-line treatment of locally advanced or metastatic cholangiocarcinoma characterized by fusion or rearrangements of fibroblast growth factor receptor (FGFR) 2. The applicant for this medicinal product is Taiho Pharma Netherlands B.V. Futibatinib was approved for medical use in the European Union in July 2023.

Names Futibatinib is the international nonproprietary name (INN).

References

Illustrations

Futibatinib illustration

Worked examples

Example 1 — a first encounter with Futibatinib

Start with the simplest possible case. Write down what Futibatinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Futibatinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Futibatinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Futibatinib

In research
Futibatinib appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Futibatinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Futibatinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Alkyne derivatives, Amines, Antineoplastic and immunomodulating drug stubs, so understanding it makes those chapters shorter.
In everyday life
Look for Futibatinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Futibatinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Futibatinib in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Futibatinib means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Futibatinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Futibatinib in simple terms?

Futibatinib, sold under the brand name Lytgobi, is an anti-cancer medication used for the treatment of cholangiocarcinoma (bile duct cancer). It is a kinase inhibitor.

Why does Futibatinib matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Futibatinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Futibatinib.

Tags

  • Alkyne derivatives
  • Amines
  • Antineoplastic and immunomodulating drug stubs
  • Antineoplastic drugs
  • Dimethoxyphenyl compounds
  • Orphan drugs
  • Pyrazolopyrimidines

Keep exploring